| 000 | 01760 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514224047.0 | ||
| 264 | 0 | _c20081103 | |
| 008 | 200811s 0 0 eng d | ||
| 022 | _a1533-4023 | ||
| 024 | 7 |
_a10.1097/01.fjc.0000166205.66555.40 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aElmarakby, Ahmed A | |
| 245 | 0 | 0 |
_aETA receptor blockade attenuates hypertension and decreases reactive oxygen species in ETB receptor-deficient rats. _h[electronic resource] |
| 260 |
_bJournal of cardiovascular pharmacology _cNov 2004 |
||
| 300 |
_aS7-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Genetically Modified |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aAorta _xdrug effects |
| 650 | 0 | 4 | _aAtrasentan |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 |
_aDinoprost _xanalogs & derivatives |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aEndothelin A Receptor Antagonists |
| 650 | 0 | 4 |
_aEndothelins _xblood |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPyrrolidines _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptor, Endothelin A _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, Endothelin B _xdeficiency |
| 650 | 0 | 4 | _aSodium Chloride, Dietary |
| 650 | 0 | 4 |
_aSuperoxides _xmetabolism |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aDabbs Loomis, E | |
| 700 | 1 | _aPollock, Jennifer S | |
| 700 | 1 | _aPollock, David M | |
| 773 | 0 |
_tJournal of cardiovascular pharmacology _gvol. 44 Suppl 1 _gp. S7-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/01.fjc.0000166205.66555.40 _zAvailable from publisher's website |
| 999 |
_c15506543 _d15506543 |
||